The Diagnosis and Treatment System of Transesophageal Echocardiography in ICU
NCT ID: NCT03811730
Last Updated: 2021-07-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
200 participants
INTERVENTIONAL
2019-03-01
2023-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Safety, Feasibility and Clinical Utility of Critical Care Transesophageal Echocardiography in Hong Kong
NCT06178471
Left Ventricular Myocardial Work for Predicting Response to CRT
NCT07319065
Transesophageal Echocardiography (TEE) and Simulation : a Preferred Learning Path
NCT06164171
Intraoperative Transesophageal Echocardiography Assessment of Portal Vein Flow and Renal Resistive Index As a Predictor of Acute Kidney Injury After Cardiac Surgery: A Prospective Observational Study
NCT04112953
Impact of Large-Volume Pleural Effusions on Heart Function
NCT02548221
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
SCREENING
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
TEE group
Eligible patients would be conducted TEE examination by researcher A,The examination results are judged by A and provided to the physician of this patient,
Transesophageal echocardiography
Eligible patients would be conducted both Transesophageal echocardiography and Transthoracic echocardiography to offer independent results
TTE group
Eligible patients would be conducted TTE examination by researcher B,The examination results are judged by B and provided to the physician of this patient,
Transesophageal echocardiography
Eligible patients would be conducted both Transesophageal echocardiography and Transthoracic echocardiography to offer independent results
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Transesophageal echocardiography
Eligible patients would be conducted both Transesophageal echocardiography and Transthoracic echocardiography to offer independent results
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. The diagnosis of the etiology by Transthoracic ultrasonography is still unclear
3. The results of Transthoracic ultrasonography are inconsistent with clinical judgment or cannot explain the existing signs.
4. No obvious improvement or even aggravation after thoracic examination and corresponding treatment
5. Special conditions or clinical scenarios
6. Other clinicians think a TEE check is required.
Exclusion Criteria
2. Did not sign an informed consent form
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kang Yan
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kang Yan
Director
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Critical Care Medicine, Peking Union Medical College Hospital, Peking Union Medical College & Chinese Academy of Medical Sciences
Beijing, , China
Xiangya Hospital Central South University
Changsha, , China
The People's Hospital of Guangxi Zhuang Autonomous Region
Nanning, , China
The First Hospital of China Medical University
Shengyang, , China
Zhongnan Hospital of Wuhan University
Wuhan, , China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Hua Zhao
Role: primary
Chenghuan Hu, PhD
Role: primary
Liwen Lv
Role: primary
Xiaohan Yin
Role: primary
Shuhan Cai, PhD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TEE
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.